234.30 1.30 (0.56%)

New 52W High in past week

3.3M NSE+BSE Volume

NSEJun 14, 2021 03:31 PM



Get corporate announcements alerts
Fortis Healthcare Ltd.    
29 May 2021
234.30
0.56%
Fortis Healthcare Ltd.    
29 May 2021
234.30
0.56%
Fortis Healthcare Ltd - 532843 - Outcome Of The Board Meeting
BSE India
Dear Sir(s), Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today inter-alia, considered and approved the Audited Standalone and Consolidated Financial results of the Company for the quarter and financial year ended March 31, 2021. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with modified opinion along with Statement of impact of Modified Opinion thereon; Accordingly, please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the Company for year ended March 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 12 Noon and concluded at 18:10 Hours IST. T
Fortis Healthcare Ltd.    
22 May 2021
234.30
0.56%
Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation ...
BSE India
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Saturday, May 29, 2021 to, inter-alia, consider and approve audited financial results for the year ended March 31, 2021. Further, in continuation to our letter ref. FHL/SEC/2020-21 dated March 31, 2021 captioned 'Closure of Trading Window', it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 31, 2021. This is for your information and record please.
Fortis Healthcare Ltd.    
29 Apr 2021
234.30
0.56%
Fortis Healthcare Ltd - 532843 - Format of Initial Disclosure to be made by an entity ...
BSE India
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayFORTIS HEALTHCARE LTD. 2CINL85110PB1996PLC045933 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 725.00 4Highest Credit Rating during the previous FY A 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: SUMIT GOEL Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: secretarial@fortishealthcare.com Name of the Chief Financial Officer: VIVEK KUMAR GOYAL Designation: CHIEF FINANCIAL OFFICER EmailId: secretarial@fortishealthcare.com Date: 29/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Fortis Healthcare Ltd.    
16 Apr 2021
234.30
0.56%
Fortis Healthcare Ltd.    
16 Apr 2021
234.30
0.56%
FORTIS HEALTHCARE LTD. - 532843 - Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, ...
BSE India
This is in continuation of our intimation dated October 18, 2018, December 22, 2018, March 20, 2019 November 13, 2020 and November 21, 2020 with respect to an ad-interim ex-parte order passed by SEBI in the matter relating to the alleged diversion of funds from the Company by its erstwhile promoters. SEBI has issued a notice under Rule 4 of SEBI (Procedure for holding inquiry and imposing penalties) Rules, 1995 read with Section 15-I of Securities and Exchange Board of India Act, 1992 in the matter of Fortis Healthcare Limited to, among others, Escorts Heart Institute and Research Center Limited (EHIRCL), a wholly owned subsidiary of the Company. The notice was received by EHIRCL on April 15, 2021. The management and Board of the Company that was newly constituted after NTK Ventures Pte. Ltd. (a wholly owned subsidiary of IHH Healthcare Berhad) became promoters of the Company, are evaluating the notice received by EHIRCL, in consultation with its legal advisors.
Fortis Healthcare Ltd.    
15 Apr 2021
234.30
0.56%
Fortis Healthcare Ltd.    
13 Apr 2021, 10:24AM
234.30
0.56%
Fortis Healthcare Ltd - 532843 - Shareholding for the Period Ended March 31, 2021
BSE India
Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
Fortis Healthcare Ltd.    
13 Apr 2021, 10:19AM
234.30
0.56%
Fortis Healthcare Ltd - 532843 - Statement Of Investor Complaints For The Quarter Ended March 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 017170 Name of the Signatory :- SUMIT GOELDesignation :- Company Secretary and Compliance Officer
Fortis Healthcare Ltd.    
13 Apr 2021, 10:19AM
234.30
0.56%
FORTIS HEALTHCARE LTD. - 532843 - Statement Of Investor Complaints For The Quarter Ended March 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 017170 Name of the Signatory :- SUMIT GOELDesignation :- Company Secretary and Compliance Officer
default
Total Votes: 204
BUY
SELL
HOLD
76.47%
12.75%
10.78%